Skip to main content

Table 1 Summary of studies and frequency table for original ordinal outcome in both studies

From: Predicting multi-level drug response with gene expression profile in multiple myeloma using hierarchical ordinal regression

Study

Mulligan et al. [10]

Terragna et al. [2]

Treatment

Bortezomib

VTD

Number of Samples

169

118

Number of Probes

22,283

54,677

Patients Population

Relapsed MM

New-Diagnosis

 

Progressive Disease (PD)

Stable Disease (SD)

 

13 (7.70%)

7 (5.93%)

 

No Change (NC)

Partial Response (PR)

 

60 (35.50%)

42 (35.59%)

 

Minimal Response (MR)

Very good partial response (VGPR)

 

12 (7.10%)

40 (33.90%)

 

Partial Response (PR)

near Complete Response (nCR)

 

43 (25.44%)

14 (11.87%)

 

Complete Response (CR)

Complete Response (CR)

 

41 (24.26%)

15 (12.71%)